Skip to content
Search

Latest Stories

Search Results for Community Pharmacy England (CPE)

NHS England to commission Midlands pharmacies to offer RSV and pertussis vaccines from May
News

Midlands pharmacies to offer RSV and pertussis vaccinations under new NHS enhanced service

Community pharmacies providing the service will receive an IoS fee of £9.58 per administered RSV or pertussis vaccine.

Shadow Health Minister raised concerns about the impact of NICs hike on healthcare
News

MPs slam government over national insurance hike, warn of impact on pharmacies

NPA estimates that rises in employer National Insurance Contributions and the minimum wage will cost the average pharmacy over £12,000 a year

PDA calls on GP practices to use funding boost to improve job security for pharmacists
News

PDA urges GP practices to ensure funding boost supports employed pharmacists

Pharmacists in some GP practices have been unable to secure permanent contracts due to “the temporary nature of existing funding”, says PDA.

Harry McQuillan, Chair, Numark
Guest Blog

Community Pharmacy: Key to Future Primary Care & Prevention

Expanding the role of pharmacists in prescribing and giving them more clinical services are dependent on sustainable funding model seen in Scotland and Wales.

By Harry McQuillan, Chair, Numark

Michelle Riddalls discusses the future of self-care and OTC medicines at a healthcare conference

“Emphasis on self-care and OTC medicines could save the NHS billions”

With the government’s recent announcement that more medicines could be reclassified for over-the-counter (OTC) use, PAGB’s Michelle Riddalls says the move could take pressure away from GPs and other NHS services.

Harry McQuillan offers insights into Numark’s 12 principles for a future model of community pharmacy practice
News

Supply-driven remuneration model holding back the sector – says Numark

Numark chairman Harry McQuillan suggests shifting the remuneration model from purely supply-driven to one with more of a patient-first clinical service focus.